Pharmacokinetic and Pharmacogenetic Predictive Markers of Irinotecan Activity and Toxicity

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|12|10|932-943

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.12, Iss.10, 2011-12, pp. : 932-943

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Mechanisms for Reduced Toxicity of Irinotecan by Coadministered Thalidomide

By  

Current Drug Metabolism, Vol. 7, Iss. 4, 2006-05 ,pp. : 431-454

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

By Cortejoso Lucía   López-Fernández Luis A  

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1173-1191

Future Medicine

Access to resources Recommend Favorite

Predictive Markers for Haematological Toxicity of Pemetrexed

By  

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 48-57

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic determinants of anti-cancer drug activity and toxicity

By Danesi R.   De Braud F.   Fogli S.   Di Paolo A.   Del Tacca M.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 8, 2001-08 ,pp. : 420-426

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World

By  

Clinical Cancer Drugs, Vol. 4, Iss. 2, 2018-01 ,pp. : 82-92

Bentham Science Publishers

Access to resources Recommend Favorite